{"protocolSection": {"identificationModule": {"nctId": "NCT02966184", "orgStudyIdInfo": {"id": "16.0721"}, "organization": {"fullName": "Norton Healthcare", "class": "OTHER"}, "briefTitle": "Comparison of Albuterol for Status Asthmaticus", "officialTitle": "Comparison of Benzalkonium Chloride Containing Albuterol Versus Preservative Free Albuterol for the Treatment of Status Asthmaticus"}, "statusModule": {"statusVerifiedDate": "2021-05", "overallStatus": "TERMINATED", "whyStopped": "Study Drug Backorder", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2018-09-10", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2018-10-25", "type": "ACTUAL"}, "completionDateStruct": {"date": "2018-10-25", "type": "ACTUAL"}, "studyFirstSubmitDate": "2016-10-26", "studyFirstSubmitQcDate": "2016-11-14", "studyFirstPostDateStruct": {"date": "2016-11-17", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2020-09-11", "resultsFirstSubmitQcDate": "2021-05-19", "resultsFirstPostDateStruct": {"date": "2021-05-20", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-05-19", "lastUpdatePostDateStruct": {"date": "2021-05-20", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Norton Healthcare", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "This study is designed to compare the length of continuous albuterol administration between two different albuterol formulations, BAC containing albuterol versus preservative free albuterol.", "detailedDescription": "The primary objective of this study is to compare the length of continuous albuterol administration between patients receiving BAC containing albuterol versus preservative free albuterol. Secondary objectives include comparison of therapy escalation, asthma scores, forced expiratory volume in one second (FEV1) at discharge, length of hospital stay, and cost."}, "conditionsModule": {"conditions": ["Status Asthmaticus"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 8, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Benzalkonium chloride (BAC) Albuterol", "type": "NO_INTERVENTION", "description": "This arm includes the current standard of care which patients receive at the institution. No interventions will be made within this group of patients."}, {"label": "Preservative Free Albuterol", "type": "EXPERIMENTAL", "description": "This arm includes the preservative free albuterol which is being investigated. Treatment for this arm will follow current standards of care, with the only difference being the albuterol formulation.", "interventionNames": ["Drug: preservative free albuterol"]}], "interventions": [{"type": "DRUG", "name": "preservative free albuterol", "description": "Preservative free albuterol for nebulization", "armGroupLabels": ["Preservative Free Albuterol"], "otherNames": ["Albuterol Sulfate Inhalation Solution 0.5%", "0487-9901-02", "0487-9901-30"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Albuterol Administration", "description": "Length of continuous albuterol administration between patients receiving BAC containing albuterol versus preservative free albuterol during hospital admission for status asthmaticus", "timeFrame": "Hours until discontinuation of therapy, an average of 72 hours"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patients will be included in the study if they are admitted to the 5th floor of Norton Children's Hospital for the treatment of an acute asthma exacerbation, initiated on continuous albuterol inhalation therapy, and are between 5 and 17 years of age.\n\nExclusion Criteria:\n\n* Patients will be excluded from the study if they are transferred from the 5th floor to the Pediatric Intensive Care Unit (PICU), admitted for any indication other than acute asthma exacerbation, or removed from the inpatient asthma protocol for any given reason.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "5 Years", "maximumAge": "17 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Tristan Murray, PharmD", "affiliation": "Norton Healthcare", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Norton Children's Hospital", "city": "Louisville", "state": "Kentucky", "zip": "40202", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO", "description": "IPD will not be made sharable."}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "According to the study design, we had to assent/consent (but not enrolled) far more patients than would be eligible for study inclusion/enrollment. This was to prevent a delay in therapy if the patient needed to be administered continuous albuterol immediately. Most consented patients did not get assigned to one of the 'study nursing units' so they were not eligible for study enrollment. Only 8 patients met the criteria for enrollment.", "groups": [{"id": "FG000", "title": "Benzalkonium Chloride-Containing Albuterol", "description": "This arm includes the current standard of care (preservative-containing albuterol nebulization) which patients receive at the institution. No interventions will be made within this group of patients."}, {"id": "FG001", "title": "Preservative-Free Albuterol", "description": "This arm includes the preservative-free albuterol nebulization which is being investigated. Treatment for this arm will follow current standards of care, with the only difference being the albuterol formulation."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "8"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "8"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "There were no patients enrolled in the Benzalkonium Chloride-Containing Albuterol group", "groups": [{"id": "BG000", "title": "Benzalkonium Chloride-Containing Albuterol", "description": "This arm includes the current standard of care (preservative-containing albuterol nebulization) which patients receive at the institution. No interventions will be made within this group of patients."}, {"id": "BG001", "title": "Preservative-Free Albuterol", "description": "This arm includes the preservative-free albuterol nebulization which is being investigated. Treatment for this arm will follow current standards of care, with the only difference being the albuterol formulation."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "8"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG001", "value": "7.78", "spread": "2.46"}, {"groupId": "BG002", "value": "7.78", "spread": "2.46"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "3"}]}, {"title": "Male", "measurements": [{"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "5"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "6"}]}, {"title": "White", "measurements": [{"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "2"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Albuterol Administration", "description": "Length of continuous albuterol administration between patients receiving BAC containing albuterol versus preservative free albuterol during hospital admission for status asthmaticus", "populationDescription": "Study was terminated due to medication backorder and therefore outcome data collection was never performed nor analyzed", "reportingStatus": "POSTED", "timeFrame": "Hours until discontinuation of therapy, an average of 72 hours", "groups": [{"id": "OG000", "title": "Benzalkonium Chloride-Containing Albuterol", "description": "This arm includes the current standard of care (preservative-containing albuterol nebulization) which patients receive at the institution. No interventions will be made within this group of patients."}, {"id": "OG001", "title": "Preservative-Free Albuterol", "description": "This arm includes the preservative-free albuterol nebulization which is being investigated. Treatment for this arm will follow current standards of care, with the only difference being the albuterol formulation."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Adverse event data was collected only during the patient's admission. Follow-up assessment after discharge did not occur", "description": "Our definition of adverse event and or serious adverse event did not differ from clinicaltrials.gov", "eventGroups": [{"id": "EG000", "title": "Benzalkonium Chloride-Containing Albuterol", "description": "This arm includes the current standard of care (preservative-containing albuterol nebulization) which patients receive at the institution. No interventions will be made within this group of patients.", "deathsNumAffected": 0, "deathsNumAtRisk": 0, "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 0, "otherNumAtRisk": 0}, {"id": "EG001", "title": "Preservative-Free Albuterol", "description": "This arm includes the preservative-free albuterol nebulization which is being investigated. Treatment for this arm will follow current standards of care, with the only difference being the albuterol formulation.", "deathsNumAffected": 0, "deathsNumAtRisk": 8, "seriousNumAffected": 0, "seriousNumAtRisk": 8, "otherNumAffected": 0, "otherNumAtRisk": 8}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Tristan Murray, PharmD", "organization": "Norton Healthcare", "email": "tristan.murray@nortonhealthcare.org", "phone": "5026295571"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2018-07-18", "uploadDate": "2020-09-11T10:50", "filename": "Prot_SAP_000.pdf", "size": 44994}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2021-05-14", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000013224", "term": "Status Asthmaticus"}], "ancestors": [{"id": "D000001249", "term": "Asthma"}, {"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M16017", "name": "Status Asthmaticus", "asFound": "Status Asthmaticus", "relevance": "HIGH"}, {"id": "M4556", "name": "Asthma", "relevance": "LOW"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000000420", "term": "Albuterol"}], "ancestors": [{"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000015149", "term": "Tocolytic Agents"}, {"id": "D000012102", "term": "Reproductive Control Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M3767", "name": "Albuterol", "asFound": "Diameter", "relevance": "HIGH"}, {"id": "M21860", "name": "Pharmaceutical Solutions", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M17869", "name": "Tocolytic Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "PhSol", "name": "Pharmaceutical Solutions"}]}}, "hasResults": true}